| CXSL1500030 | SHR-1309注射液 | pertuzumab | Injection | Biological Products(2) | New Drug Application | 2015-05-13 | 上海恒瑞医药有限公司 | Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2017-02-21 | view |
| JXSL1300083 | 帕妥珠单抗 | pertuzumab | Injection | Biological Products | Import Drug Application | 2014-01-03 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2015-10-19 | view |
| JXSL0800003 | 帕妥珠单抗注射剂 | pertuzumab | Injection | Biological Products | Import Drug Application | 2008-03-12 | F.Hoffmann-La Roche Ltd. | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2010-01-29 | view |
| JYSB2000696 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-01-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2021-03-17 | view |
| JXSL1300034 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2013-05-23 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2015-08-10 | view |
| JYSB2300063 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-04-11 | | | | | view |
| JXSL1800044 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2018-10-29 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2018-10-26 | view |
| JYSB2000386 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-02 | view |
| JYSB2200111 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2022-06-30 | | | | | view |
| JXSS1700018 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2018-01-02 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2018-12-19 | view |
| JYSB1900363 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-01-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-03-24 | view |
| JYSB2000662 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-12-24 | view |
| JXSL1200073 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2012-12-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2014-02-07 | view |
| JYSB2300016 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-02-07 | | | | | view |
| JYSB1800226 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2018-10-26 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2018-12-19 | view |
| JYSB2000140 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-05-06 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-01 | view |
| JYSB2101061 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-06-25 | | | | | view |
| CXSL1700090 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products(2) | New Drug Application | 2017-10-18 | 正大天晴药业集团南京顺欣制药有限公司 | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | Certificate Issued | 2018-05-08 | view |
| JYSB2300197 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-11-14 | | | | | view |
| JYSB1900081 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2019-04-11 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2019-12-13 | view |
